Pharmaceutical giant Sandoz has announced a significant investment in a new drug substance manufacturing facility located in Ljubljana, Slovenia. This strategic move underscores the company’s commitment to expanding its production capabilities and strengthening its position in the global generics and biosimilars market. The new facility is expected to enhance Sandoz’s capacity to meet growing demand while supporting innovation and supply chain resilience in the region.
Sandoz Expands Manufacturing Capabilities with New Ljubljana Facility
Sandoz, a global leader in generic pharmaceuticals and biosimilars, has significantly boosted its production footprint with the inauguration of a state-of-the-art drug substance manufacturing facility in Ljubljana, Slovenia. This strategic investment aims to enhance the company’s supply chain resilience and support the growing demand for high-quality, affordable medicines across Europe and beyond. The new facility is equipped with…
—-
Author : William Green
Publish date : 2026-09-09 04:20:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
